Oncology— Companies & Signals
The Oncology investment theme centers on companies developing novel treatments for a broad spectrum of cancers, addressing a critical and growing global health challenge. This sector offers significant growth potential driven by unmet medical needs, advancements in scientific understanding, and an aging population. 184 public companies above the $50M floor. Last 90 days: 92 red 8-Ks, 0 insider cluster-buys, 19 running hot in the press.
184
Companies
92
Red 8-Ks · 90d
0
Insider clusters
19
🔥 Media-hot
Companies in Oncology
Refine in search →| # | Ticker | Company | Sector | Mkt cap | 1D | 5D | Volume | Heat | Signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | PYXS | Pyxis Oncology, Inc. | Healthcare | $111.5M | +3.3% | +34.3% | 1.3M | — | red 8-K |
| 2 | EXEL | EXELIXIS, INC. | Healthcare | $13.4B | -0.9% | +5.7% | 2.6M | — | red 8-K |
| 3 | CMPX | Compass Therapeutics, Inc. | Healthcare | $365.6M | +3.9% | +2.9% | 2.8M | — | |
| 4 | CBIO | CRESCENT BIOPHARMA, INC. | Healthcare | $494.1M | -3.0% | +2.5% | 432K | — | |
| 5 | BCAX | Bicara Therapeutics Inc. | Healthcare | $1.4B | +9.2% | +19.5% | 1.6M | — | |
| 6 | HURA | TuHURA Biosciences, Inc./NV | Healthcare | $147.7M | +6.0% | -15.5% | 794K | — | red 8-K |
| 7 | AVBP | ArriVent BioPharma, Inc. | Healthcare | $1.4B | +1.1% | +5.1% | 486K | — | |
| 8 | ALLO | Allogene Therapeutics, Inc. | Healthcare | $655.8M | +4.2% | +5.7% | 14.7M | — | red 8-K |
| 9 | STRO | SUTRO BIOPHARMA, INC. | Healthcare | $477.2M | +9.3% | +5.7% | 465K | — | |
| 10 | IMNM | Immunome Inc. | Healthcare | $2.1B | +5.4% | +9.7% | 1.6M | — | |
| 11 | NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | Healthcare | $123.6M | -3.3% | -13.3% | 54K | — | |
| 12 | ZLAB | Zai Lab Ltd | Healthcare | $1.9B | +2.3% | -0.4% | 945K | — | red 8-K |
| 13 | PBYI | PUMA BIOTECHNOLOGY, INC. | Healthcare | $373.1M | +1.0% | +6.9% | 345K | — | |
| 14 | XNCR | Xencor Inc | Healthcare | $914.2M | +3.6% | +11.3% | 750K | — | red 8-K |
| 15 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Healthcare | $1.8B | -0.9% | +3.7% | 10.7M | — | |
| 16 | MGNX | MACROGENICS INC | Healthcare | $251.7M | +1.0% | +6.1% | 1.4M | — | |
| 17 | INBX | Inhibrx Biosciences, Inc. | Healthcare | $1.4B | +0.7% | +2.4% | 411K | — | |
| 18 | CHRS | Coherus Oncology, Inc. | Healthcare | $215.9M | -3.3% | -2.0% | 1.1M | — | red 8-K |
| 19 | MAIA | MAIA Biotechnology, Inc. | Healthcare | $79.0M | +5.0% | +7.3% | 772K | — | red 8-K |
| 20 | ARVN | ARVINAS, INC. | Healthcare | $489.1M | +3.6% | +7.1% | 955K | — | red 8-K |
| 21 | ZYME | Zymeworks Inc. | Healthcare | $1.7B | -0.2% | +3.6% | 1.1M | — | |
| 22 | MRK | Merck & Co., Inc. | Healthcare | $294.0B | +0.6% | +12.0% | 9.6M | ⚡ | |
| 23 | REPL | Replimune Group, Inc. | Healthcare | $733.2M | -3.7% | +0.2% | 3.7M | — | |
| 24 | PGEN | PRECIGEN, INC. | Healthcare | $1.6B | +1.0% | +10.0% | 6.3M | — | red 8-K |
| 25 | ERAS | Erasca, Inc. | Healthcare | $4.4B | +14.2% | +21.3% | 8.0M | — | |
| 26 | WHWK | Whitehawk Therapeutics, Inc. | Healthcare | $205.7M | +6.0% | -1.1% | 364K | — | |
| 27 | SMMT | Summit Therapeutics Inc. | Healthcare | $10.9B | +2.2% | +0.3% | 6.0M | 🔥 | |
| 28 | SRRK | Scholar Rock Holding Corp | Healthcare | $5.3B | +0.4% | +11.7% | 2.1M | — | |
| 29 | MRNA | Moderna, Inc. | Healthcare | $19.8B | +3.6% | +17.4% | 8.1M | 🔥 | |
| 30 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Healthcare | $151.7M | +2.8% | +8.1% | 418K | 🔥 | red 8-K |
| 31 | IBIO | iBio, Inc. | Healthcare | $84.0M | +3.6% | -0.6% | 1.1M | — | red 8-K |
| 32 | NVCT | Nuvectis Pharma, Inc. | Healthcare | $284.1M | +4.9% | +72.6% | 519K | — | |
| 33 | RIGL | RIGEL PHARMACEUTICALS INC | Healthcare | $607.8M | +0.9% | +9.3% | 284K | — | red 8-K |
| 34 | MYGN | MYRIAD GENETICS INC | Healthcare | $409.0M | -0.5% | +30.0% | 1.9M | — | red 8-K |
| 35 | SGMT | Sagimet Biosciences Inc. | Healthcare | $400.2M | +10.3% | +9.7% | 1.4M | — | red 8-K |
| 36 | LIXT | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Healthcare | $107.6M | +11.8% | +7.5% | 782K | — | red 8-K |
| 37 | ZNTL | Zentalis Pharmaceuticals, Inc. | Healthcare | $266.9M | +14.1% | +25.6% | 2.8M | — | red 8-K |
| 38 | LLY | ELI LILLY & Co | Healthcare | $1010.3B | +1.8% | +11.6% | 3.7M | 🔥 | |
| 39 | FLGT | Fulgent Genetics, Inc. | Healthcare | $530.5M | +2.9% | +15.1% | 295K | — | red 8-K |
| 40 | IMRX | Immuneering Corp | Healthcare | $271.1M | +6.1% | +13.7% | 1.9M | — | red 8-K |
| 41 | RXRX | RECURSION PHARMACEUTICALS, INC. | Healthcare | $1.7B | +4.8% | +16.0% | 22.9M | — | red 8-K |
| 42 | VSTM | Verastem, Inc. | Healthcare | $360.3M | +1.1% | -10.1% | 2.7M | — | |
| 43 | GH | Guardant Health, Inc. | Healthcare | $17.5B | +3.0% | +19.3% | 2.7M | ⚡ | red 8-K |
| 44 | BCYC | BICYCLE THERAPEUTICS PLC | Healthcare | $282.7M | +1.2% | +4.3% | 784K | — | |
| 45 | CTMX | CytomX Therapeutics, Inc. | Healthcare | $655.3M | +10.0% | +23.0% | 7.0M | — | red 8-K |
| 46 | JANX | Janux Therapeutics, Inc. | Healthcare | $826.9M | +2.6% | +6.9% | 1.2M | — | red 8-K |
| 47 | KZIA | KAZIA THERAPEUTICS LTD | Healthcare | $163.2M | +1.7% | +3.3% | 195K | — | |
| 48 | CGEN | COMPUGEN LTD | Healthcare | $193.0M | +3.4% | +4.3% | 257K | — | |
| 49 | OSTX | OS Therapies Inc | Healthcare | $75.7M | +19.1% | +23.1% | 2.0M | — | |
| 50 | NVCR | NovoCure Ltd | Healthcare | $2.1B | +0.3% | +13.7% | 1.1M | ⚡ | red 8-K |
| 51 | NTRA | Natera, Inc. | Healthcare | $30.4B | +4.0% | +19.0% | 1.8M | 🔥 | red 8-K |
| 52 | FHTX | Foghorn Therapeutics Inc. | Healthcare | $245.4M | +15.2% | +16.3% | 389K | — | |
| 53 | BLLN | BillionToOne, Inc. | Healthcare | $4.7B | +1.9% | +19.5% | 607K | ⚡ | |
| 54 | NRIX | Nurix Therapeutics, Inc. | Healthcare | $1.8B | +4.2% | +27.9% | 2.7M | 🔥 | |
| 55 | CAI | Caris Life Sciences, Inc. | Healthcare | $5.1B | -1.0% | +5.8% | 3.8M | — | |
| 56 | NUVL | Nuvalent, Inc. | Healthcare | $9.8B | -0.0% | +0.1% | 1.3M | 🔥 | |
| 57 | ELTX | Elicio Therapeutics, Inc. | Healthcare | $283.4M | 0.0% | -3.4% | 456K | — | |
| 58 | MOLN | MOLECULAR PARTNERS AG | Healthcare | $154.2M | +4.2% | +0.3% | 9K | — | |
| 59 | AZN | ASTRAZENECA PLC | Healthcare | $277.2B | +1.4% | +8.2% | 1.6M | 🔥 | |
| 60 | DCTH | DELCATH SYSTEMS, INC. | Healthcare | $404.6M | +0.1% | +12.5% | 641K | — | red 8-K |
Membership is matched by keyword from companies’ SEC business descriptions (10-K Item 1) — deterministic, not AI inference. May not be exhaustive; not investment advice.